Stocks and Investing Stocks and Investing
Fri, October 4, 2024

Brian Abrahams Maintained (BIIB) at Buy with Decreased Target to $269 on, Oct 4th, 2024


Published on 2024-10-28 14:38:44 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $292 to $269 on, Oct 4th, 2024.

Brian has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $202 on, Thursday, October 3rd, 2024
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $205 on, Monday, September 23rd, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $225 on, Friday, August 2nd, 2024
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $190 on, Friday, August 2nd, 2024


These are the ratings of the 7 analyists that currently disagree with Brian


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $285 on, Tuesday, September 24th, 2024
  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $292 on, Monday, September 9th, 2024
  • Salim Syed of "Mizuho" Maintained at Buy with Decreased Target to $251 on, Tuesday, August 6th, 2024
  • Srikripa Devarakonda of "Truist Securities" Reiterated at Strong Buy with Decreased Target to $302 on, Monday, August 5th, 2024
  • George Farmer of "Scotiabank" Maintained at Buy with Decreased Target to $244 on, Friday, August 2nd, 2024
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
Contributing Sources